Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.73) by 1.37 percent. This is a 22.03 percent decrease over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $3.078 million which beat the analyst consensus estimate of $1.915 million by 60.70 percent.